AJJ Medtech and Autagco Announce Strategic Partnership to Deploy Humanoid Elderly Care Robots in Singapore

Key Points Investors Should Note

• AJJ Medtech Holdings Limited (SGX-listed) and Autagco Ltd. (SGX-listed) have signed a legally binding Strategic Cooperation Memorandum of Understanding (MOU).
• The partnership focuses on deploying and commercialising AI-powered Humanoid Elderly Care Robots within Autagco’s assisted living facilities.
• Initial pilot involves Autagco acquiring six (6) units of AJJ-HT-X1 Humanoid Elderly Care Robots for progressive deployment.
• Clinical trials and operational applications will be conducted within Autagco’s facilities, validating safety, medical effectiveness, and functional capabilities, including companionship, rehabilitation assistance, health monitoring, and cognitive interaction.
• The MOU is valid for 36 months and may be renewed upon agreement by both parties.
• Both companies will share resources and coordinate with local and international institutions to ensure compliance with medical regulations and accelerate product validation.

Strategic Details and Potential Impact on Shareholders

Transformative Technology for Elderly Care

The collaboration brings together AJJ Medtech’s expertise in humanoid robotics, artificial intelligence, and digital health solutions with Autagco’s operational know-how in assisted living. This partnership positions both companies at the forefront of technology-driven eldercare, aiming to convert Autagco’s facilities into AI-powered intelligent care environments. This model sets a potential benchmark for scalable, high-quality eldercare services in Singapore and beyond.

Pilot Project and Clinical Validation

The initial phase involves a pilot project with Autagco acquiring six AJJ-HT-X1 robots for deployment across its facilities. These robots will undergo clinical trials to validate their safety and operational effectiveness under Singapore’s medical regulations. The trials will assess their capabilities in providing companionship, rehabilitation support, health monitoring, and cognitive engagement for elderly residents. This step is crucial for regulatory approval and commercial adoption.

Operational and Regulatory Responsibilities

• AJJ Medtech will provide the robot hardware and technology, manage clinical trial applications, and obtain regulatory approvals (including registration with the Health Sciences Authority).
• Autagco will offer its facilities for trials and deployment, facilitate staff training, operational integration, and support commercialisation within its communities.
• Both companies will collaborate to ensure compliance with all relevant laws and medical regulations, liaising with local and international medical and eldercare institutions.

Long-Term Vision and Strategic Opportunities

The partnership’s long-term goal is to fully integrate AI-powered humanoid robots across all Autagco’s assisted living facilities, accelerating product validation and operational readiness for widespread deployment. This could significantly enhance the quality of care and operational efficiency, potentially reshaping the assisted living sector and creating a competitive advantage for both companies.

Potentially Price-Sensitive Information

• The legally binding nature of the MOU and the planned pilot and deployment of advanced robotics could be seen as a material development, potentially impacting share prices due to future revenue streams, market positioning, and regulatory milestones.
• Successful clinical validation and regulatory approval could unlock significant commercial potential, making both AJJ Medtech and Autagco attractive to investors interested in healthcare innovation and technology-driven growth.
• The MOU is valid for 36 months, with possible renewal, indicating a sustained commitment to the project that may impact future earnings and strategic outlook.

About Autagco Ltd.

Autagco Ltd. is listed on the Catalist Board of the Singapore Exchange. Through its wholly-owned subsidiary, Communa Gold Pte Ltd, Autagco manages and develops premium senior assisted living communities. These communities integrate hospitality services, personalised wellness programs, and technology-driven care for active seniors seeking independent living with support and community engagement.

Media & Investor Contact

Mr. Patrick Loke
Executive Director and Head of Corporate Development
Phone: +65 9818 9070
Email: [email protected]

Important Disclaimer

This article is prepared for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Shareholders and prospective investors should refer to official company announcements and consult their financial advisors before making any investment decisions. The Singapore Exchange Securities Trading Limited (SGX-ST) has not examined or approved the contents of this release and assumes no responsibility for its correctness.

View Autagco Historical chart here